Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Nanobiotix Plans to Conduct Registered Public Offering in the United States

Abstract:
NANOBIOTIX SA (Euronext : NANO – ISIN : FR0011341205) announced today that it plans to conduct a registered public offering of its ordinary shares, including in the form of American Depositary Shares (ADSs) in the United States, and has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission. The timing, number of new ordinary shares and ADSs to be issued, the price of such shares and ADSs, and the other terms of the proposed offering have not yet been determined.

Nanobiotix Plans to Conduct Registered Public Offering in the United States

Paris, France and Cambridge, MA | Posted on January 17th, 2019

This announcement is being made pursuant to and in accordance with Rule 135 under the Securities Act of 1933. This press release does not, and is not intended to, constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

####

About Nanobiotix
Incorporated in 2003, Nanobiotix is a late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.



Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP). The Company’s headquarters are based in Paris, France, with a U.S. affiliate in Cambridge, MA, and European affiliates in Spain and Germany.

For more information, please click here

Contacts:
Nanobiotix



Sarah Gaubert

Director, Communication & Public Affairs

+33 (0)1 40 26 07 55

/









Noël Kurdi
Director, Investor Relations
+1 (646) 241-4400
/



Ricky Bhajun
Investor Relations Europe
+33 (0)1 79 97 29 99
/

Media relations





France - Springbok Consultants

Marina Rosoff

+33 (0)6 71 58 00 34







United States – RooneyPartners

Marion Janic

+1 (212) 223-4017

Copyright © Nanobiotix

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Improving quantum computers April 19th, 2019

Electric skyrmions charge ahead for next-generation data storage: Berkeley Lab-led research team makes a chiral skyrmion crystal with electric properties; puts new spin on future information storage applications April 18th, 2019

A light-activated remote control for cells April 17th, 2019

NEXUS 2019: Global Summit on Energy Materials and Green Nanotechnology April 16th, 2019

Govt.-Legislation/Regulation/Funding/Policy

Electric skyrmions charge ahead for next-generation data storage: Berkeley Lab-led research team makes a chiral skyrmion crystal with electric properties; puts new spin on future information storage applications April 18th, 2019

A light-activated remote control for cells April 17th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

New microscopy method provides more details about nanocomposites April 12th, 2019

Possible Futures

Improving quantum computers April 19th, 2019

Electric skyrmions charge ahead for next-generation data storage: Berkeley Lab-led research team makes a chiral skyrmion crystal with electric properties; puts new spin on future information storage applications April 18th, 2019

A light-activated remote control for cells April 17th, 2019

Oregon scientists drill into white graphene to create artificial atoms: Patterned on a microchip and working in ambient conditions, the atoms could lead to rapid advancements in new quantum-based technology April 12th, 2019

Investments/IPO's/Splits

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019

Nanometrics Announces $80 Million Share Repurchase Program March 14th, 2019

A Nanobiotechnology Startup from a small town in India attracts the Global Investors January 27th, 2019

Nanometrics to Participate in the 21st Annual Needham Growth Conference January 7th, 2019

Nanomedicine

A light-activated remote control for cells April 17th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

Arrowhead Presents Clinical Data on JNJ-3989 (ARO-HBV) at The International Liver Congress™ April 12th, 2019

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

Announcements

Improving quantum computers April 19th, 2019

Electric skyrmions charge ahead for next-generation data storage: Berkeley Lab-led research team makes a chiral skyrmion crystal with electric properties; puts new spin on future information storage applications April 18th, 2019

A light-activated remote control for cells April 17th, 2019

NEXUS 2019: Global Summit on Energy Materials and Green Nanotechnology April 16th, 2019

Nanobiotechnology

A light-activated remote control for cells April 17th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

Arrowhead Presents Clinical Data on JNJ-3989 (ARO-HBV) at The International Liver Congress™ April 12th, 2019

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project